A major prospective cohort study published in JAMA Network Open examined the effectiveness of U.S. Preventive Services Task Force guidelines for preeclampsia risk assessment. The research, which analyzed data from 5,684 pregnancies across 11 medical centers, found that current guidelines identify 89% of pregnant individuals as being at increased risk for preeclampsia, raising questions about the specificity and clinical utility of existing risk stratification approaches.
Kara Boeldt, Executive Director of EndPreeclampsia and a preeclampsia survivor, provided expert commentary for the Contemporary OB/GYN coverage: “The introduction of the USPSTF guidelines in 2021 didn’t do anything to reverse course on the rise of preeclampsia. This important and eye-opening study highlights that we need new approaches that can predict who’s truly at risk for preeclampsia, which can be so dangerous for moms and their babies.”
Research StudyRead the full article at Contemporary OB/GYN Read the full article at Contemporary OB/GYN